Publication | Closed Access

Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-κB activation

InflammationMolecular PharmacologyCytokineAnti-inflammatoryMedicineImmunologyImmune RegulationChronic InflammationVascular BiologyImmune FunctionCox-2 ExpressionImmunosuppressionNf-κb ActivationPharmacologyInflammatory DiseaseLipopolysaccharide-induced Inos